Anti-Snoring Devices Market Size, Share, Technological Innovations, and Forecast 2032
- sachi toshniwal
- 3 hours ago
- 4 min read
The Anti-Snoring Devices Market focuses on products designed to reduce or eliminate snoring by improving airflow during sleep. These devices address issues such as nasal congestion, airway obstruction, or soft palate vibration—common causes of snoring—and are used both for lifestyle improvement and to manage mild cases of sleep apnea. The market includes a variety of solutions such as mandibular advancement devices (MADs), tongue stabilizing devices, nasal dilators, chin straps, and smart anti-snoring wearables.
According to Fortune Business Insights, the anti-snoring devices market share was valued at USD 1.07 billion in 2024 and is projected to grow from USD 1.15 billion in 2025 to USD 1.94 billion by 2032, exhibiting a CAGR of 7.7% during the forecast period. North America dominated the market, accounting for a 40.18% share in 2024.
𝗠𝗮𝗿𝗸𝗲𝘁 𝗥𝗲𝗽𝗼𝗿𝘁 𝗖𝗼𝘃𝗲𝗿𝗮𝗴𝗲
The anti-snoring devices market report provides a detailed analysis of industry dynamics, covering revenue forecasts, regional trends, device types, and distribution channels from 2019 to 2032. It evaluates growth drivers, restraints, and opportunities shaping the market’s competitive environment while highlighting recent product innovations and regulatory developments.
𝗧𝗼𝗽 𝗖𝗼𝗺𝗽𝗮𝗻𝗶𝗲𝘀 𝗜𝗻 𝗧𝗵𝗲 𝗠𝗮𝗿𝗸𝗲𝘁
SomnoMed (Australia)
ResMed (U.S.)
Glidewell (U.S.)
PANTHERA DENTAL (Canada)
Frantz Design Inc. (U.S.)
BlueSleep (U.S.)
ProSomnus Sleep Technologies (U.S.)
Fisher & Paykel Healthcare Limited (New Zealand)
Apnea Sciences (U.S.)
DynaFlex (U.S.)
𝗠𝗮𝗿𝗸𝗲𝘁 𝗗𝗿𝗶𝘃𝗲𝗿𝘀 & 𝗥𝗲𝘀𝘁𝗿𝗮𝗶𝗻𝘁𝘀
Market Drivers
Rising prevalence of sleep disorders: Increasing cases of snoring and obstructive sleep apnea are prompting more people to seek treatment, boosting product demand.
Preference for non-invasive solutions: Anti-snoring devices are gaining popularity due to their affordability and ease of use compared to surgical or continuous positive airway pressure (CPAP) therapy.
Technological innovation: The introduction of more comfortable, adjustable, and digitally connected devices is enhancing user adoption and long-term compliance.
Market Restraints
Lack of awareness: In developing regions, many people still perceive snoring as a minor issue rather than a medical condition, hindering early diagnosis and treatment adoption.
Competition from alternative therapies: CPAP devices and surgical interventions continue to limit market penetration of anti-snoring products in certain patient groups.
𝗠𝗮𝗿𝗸𝗲𝘁 𝗖𝗼𝗺𝗽𝗲𝘁𝗶𝘁𝗶𝘃𝗲 𝗟𝗮𝗻𝗱𝘀𝗰𝗮𝗽𝗲
Leading companies are investing heavily in research and development to enhance device comfort, efficiency, and durability. Partnerships between manufacturers and sleep clinics are becoming common to expand product reach and improve patient outcomes. ResMed and Fisher & Paykel Healthcare Limited are focusing on product diversification, while SomnoMed continues to strengthen its presence through innovative mandibular advancement devices. Startups and mid-sized players like BlueSleep and ProSomnus are leveraging digital platforms to improve accessibility and consumer engagement.
𝗠𝗮𝗿𝗸𝗲𝘁 𝗦𝗲𝗴𝗺𝗲𝗻𝘁𝘀
By Device Type
Mandibular Advancement Devices (MADs): The most widely adopted segment in 2024 due to user comfort and proven efficacy for mild to moderate sleep apnea.
Tongue Retaining Devices (TRDs): Expected to grow steadily, especially for patients intolerant to MADs.
Nasal Devices: Increasing acceptance driven by enhanced airflow designs and affordability.
Others: Includes chin straps and positional therapy devices, used in combination therapies.
By Distribution Channel
Retail Pharmacies: Accounted for the largest market share in 2024, supported by strong consumer accessibility.
Online Pharmacies: Expected to register the fastest growth due to convenience and the rising popularity of direct-to-consumer models.
Hospital Pharmacies: Maintain a steady share through integration with clinical sleep treatment programs.
Explore the full research report with detailed insights and TOC: https://www.fortunebusinessinsights.com/anti-snoring-device-market-105114
𝗠𝗮𝗿𝗸𝗲𝘁 𝗥𝗲𝗴𝗶𝗼𝗻𝗮𝗹 𝗜𝗻𝘀𝗶𝗴𝗵𝘁𝘀
North America: Dominated the global market with over 40% share in 2024, driven by high healthcare spending, strong awareness, and widespread product availability.
Europe: Witnessing steady growth supported by government sleep health initiatives and expanding reimbursement coverage for sleep therapy devices.
Asia Pacific: Expected to exhibit the fastest growth due to large population base, rising disposable incomes, and growing awareness in China, Japan, and India.
Latin America: Gradual expansion as private healthcare sectors adopt more advanced sleep management technologies.
Middle East & Africa: Emerging region with increasing adoption in GCC countries driven by medical tourism and awareness campaigns.
𝗙𝘂𝘁𝘂𝗿𝗲 𝗠𝗮𝗿𝗸𝗲𝘁 𝗦𝗰𝗼𝗽𝗲
The future outlook for the anti-snoring devices market remains optimistic. Growing emphasis on preventive healthcare and home-based treatment solutions will continue to shape innovation trends. Manufacturers are likely to integrate smart technologies such as sensors and mobile connectivity, enabling users to monitor and manage snoring patterns effectively. Expansion into emerging economies through digital platforms and e-commerce will further broaden market reach.
In March 2025, Signifier Medical Technologies Limited announced an upgraded version of its eXciteOSA device to meet CMS (Medicare & Medicaid) reimbursement requirements—enhancing patient access and affordability across the United States. Such developments highlight the increasing integration of regulatory compliance and patient-centric innovation in market strategies.
Conclusion
The anti-snoring devices market is entering a new phase of digital transformation and consumer awareness. The growing focus on sleep health, coupled with ongoing advancements in device technology, positions the industry for sustained expansion through 2032. Companies that innovate in comfort, connectivity, and accessibility are likely to capture the greatest growth opportunities in this evolving landscape.
Contact us:
Fortune Business Insights™ Pvt.
Phone: USA: +1 833 909 2966 (Toll-Free),
United Kingdom: +44 808 502 0280 (Toll-Free),
APAC: +91 744 740 1245
Comments